Purpose
This study offers a lens for exploring women leaders’ production of resistance through postfeminist discourses. Through the case study of Bozoma Saint John, a high-profile Black C-Suite executive, this study examines micro-acts of subversion and considers the extent they can promote feminist thinking in the corporate world and the implications for feminist theorising about women in leadership.
Design/methodology/approach
Interviews with Saint John were collected from YouTube and examined using feminist critical discourse analysis informed by intersectionality, feminist poststructuralism and Foucault’s notion of “reverse discourse”.
Findings
Saint John reproduces elements of the postfeminist confidence discourse to defy stereotypes of Black women, while simultaneously reversing the individualistic conception of confidence in favour of corporate and collective action. This has the potential to facilitate positive change, albeit within the boundaries of the confidence culture.
Research limitations/implications
Combining reverse discourse, intersectionality and feminist poststructuralism with a micro-level analysis of women leaders’ language use can help to capture the ways postfeminist concepts are given new subversive meanings.
Originality/value
Whereas existing studies have focused on how elite women’s promotion of confidence sustains the status quo, this study shifts the research gaze to the resistance realised through rearticulations of confidence, illustrating how women-in-leadership research can advance feminist theorising without vilifying senior women even as they participate in postfeminist logics of success.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.